Caudal Vena Cava Thrombosis and Pulmonary Hemorrhage

Caudal vena cava thrombosis (CVCT) is a severe, often fatal cardiovascular disorder of cattle, characterized by the formation of a thrombus within the caudal vena cava, typically originating from septic emboli arising from foci of infection in the gastrointestinal tract, liver, or other abdominal organs. The thrombus may extend into the right atrium and pulmonary arteries, leading to pulmonary hypertension, pulmonary infarction, and subsequent pulmonary hemorrhage. Clinically, the disease manifests as acute respiratory distress, hemoptysis, anemia, and sudden death. It is most commonly observed in adult dairy cattle, particularly high-producing cows in early lactation, and is associated with ruminal acidosis, hepatic abscessation, and other suppurative processes. The condition carries a grave prognosis, with mortality rates approaching 100% despite aggressive therapy. Economically, CVCT results in significant losses due to death, decreased milk production, and increased culling rates.

The primary etiology of CVCT is septic thromboembolism, with the most common source being hepatic abscesses caused by Fusobacterium necrophorum and Trueperella pyogenes. These anaerobic and facultative bacteria gain access to the portal circulation through ruminal lesions, often secondary to ruminal acidosis and rumenitis. Other sources include abdominal abscesses, mastitis, metritis, and traumatic reticuloperitonitis. The bacteria produce virulence factors such as leukotoxin (F. necrophorum) and proteases, which damage vascular endothelium and promote thrombus formation. Additionally, coagulase-positive staphylococci and coliforms may be involved. The thrombus typically forms in the caudal vena cava at the level of the liver, where turbulent blood flow and endothelial injury occur. Extension of the thrombus into the pulmonary vasculature leads to pulmonary infarction and hemorrhage. In some cases, the thrombus may be sterile, but septic emboli are more common. Nutritional factors, particularly high-concentrate diets causing ruminal acidosis, are critical in predisposing to hepatic abscessation and subsequent CVCT.

CVCT is predominantly a disease of adult dairy cattle, with the highest incidence in high-producing cows during the first 60 days of lactation. It is less common in beef cattle and young stock. The condition is sporadic, with herd-level morbidity typically less than 1%, but case fatality rates are extremely high, often exceeding 90%. Economic losses arise from death, premature culling, reduced milk yield, and treatment costs. Breed predilections are not well-documented, but Holstein-Friesian cattle are overrepresented due to their prevalence in dairy systems. Management factors such as high-energy diets, inadequate fiber, and poor bunk management increase the risk of ruminal acidosis and hepatic abscessation. Seasonal patterns are not consistent, but the disease may be more frequent in winter when cattle are housed and fed high-concentrate rations. The presence of concurrent diseases, such as mastitis or metritis, may also increase the risk of septicemia and thromboembolism.

The pathophysiology of CVCT begins with ruminal acidosis, which damages the ruminal epithelium, allowing Fusobacterium necrophorum and other bacteria to enter the portal circulation. These bacteria colonize the liver, forming abscesses. The abscesses may erode into the caudal vena cava, causing endothelial injury and initiating thrombus formation. The thrombus, composed of fibrin, platelets, and bacteria, enlarges and may partially or completely occlude the vessel. Septic emboli detach and travel to the lungs, where they lodge in pulmonary arteries, causing infarction and necrosis of lung tissue. This leads to pulmonary hemorrhage, which may be massive and fatal. The release of bacterial toxins and inflammatory mediators induces systemic inflammatory response syndrome (SIRS), characterized by fever, leukocytosis or leukopenia, and cardiovascular instability. Pulmonary hypertension develops due to vascular obstruction, leading to right heart failure and peripheral edema. The clinical signs of hemoptysis and anemia result from pulmonary hemorrhage. In some cases, the thrombus may extend into the right atrium, causing tricuspid valve insufficiency and congestive heart failure.

Intrinsic risk factors include high milk production, which necessitates high-energy diets and increases susceptibility to ruminal acidosis. Parity and genetics may influence individual susceptibility, with older cows more commonly affected. Transition period stress, including parturition and lactation onset, can suppress immune function, increasing the risk of infection. Extrinsic factors include ration formulation errors, such as excessive non-fiber carbohydrates and insufficient effective fiber, leading to ruminal acidosis. Poor feed bunk management, feed sorting, and sudden diet changes exacerbate the problem. Inadequate housing ventilation and overcrowding contribute to stress and disease transmission. Dirty bedding and poor hygiene increase the risk of mastitis and metritis, which can serve as sources of septic emboli. Unhygienic milking procedures may also introduce bacteria into the udder, leading to mastitis and potential systemic spread.

Clinical signs of CVCT vary depending on the extent of thrombosis and embolization. Acute cases present with sudden onset of severe respiratory distress, tachypnea, dyspnea, and hemoptysis (coughing up blood). Affected cattle may be found dead without premonitory signs. Subacute cases show progressive weight loss, decreased milk production, fever, and intermittent hemoptysis. On physical examination, cattle may have pale mucous membranes, tachycardia, and increased respiratory effort. Auscultation of the lungs may reveal crackles, wheezes, and areas of consolidation. Cardiac auscultation may reveal a murmur if the thrombus extends to the heart. Jugular venous distension and peripheral edema may occur if right heart failure develops. In some cases, there may be evidence of hepatic abscessation, such as hepatomegaly or pain on deep palpation. The disease should be suspected in any adult dairy cow with acute respiratory distress and hemoptysis, especially in the early lactation period.

Differential diagnoses for CVCT include: 1) Severe pneumonia (e.g., Mannheimia haemolytica, Pasteurella multocida) – typically associated with nasal discharge, fever, and lung consolidation, but hemoptysis is rare. 2) Pulmonary thromboembolism from other sources (e.g., jugular vein thrombosis) – may present similarly but lacks hepatic abscessation. 3) Traumatic reticuloperitonitis (hardware disease) – may cause abdominal pain and fever, but respiratory signs are less prominent. 4) Right-sided heart failure due to valvular endocarditis – may cause jugular distension and edema, but hemoptysis is uncommon. 5) Lung abscessation or neoplasia – may cause chronic weight loss and respiratory signs, but acute hemoptysis is less typical. 6) Acute respiratory distress syndrome (ARDS) – can cause severe dyspnea but is not associated with hemoptysis. 7) Severe anemia from other causes (e.g., hemorrhage, hemolysis) – may cause pale mucous membranes and weakness, but respiratory signs are less prominent. 8) Aspiration pneumonia – may cause coughing and fever, but history of aspiration is usually present. 9) Pulmonary hemorrhage due to trauma – rare in cattle. 10) Congestive heart failure from cardiomyopathy – may cause edema and respiratory distress, but hemoptysis is unusual. Definitive diagnosis requires imaging or necropsy.

The diagnostic approach for CVCT should be systematic: 1) Obtain a thorough history, including diet, production stage, and recent health issues. 2) Perform a complete physical examination, with emphasis on respiratory and cardiovascular systems. Note any hemoptysis, fever, tachycardia, and abnormal lung sounds. 3) Assess for signs of right heart failure (jugular distension, edema). 4) Perform a complete blood count (CBC) and serum biochemistry, looking for leukocytosis with left shift, anemia, hyperfibrinogenemia, and elevated liver enzymes. 5) Submit blood cultures if septicemia is suspected. 6) Perform thoracic radiography or ultrasonography to identify pulmonary lesions, pleural effusion, or cardiac changes. 7) Abdominal ultrasonography may reveal hepatic abscesses or thrombus in the caudal vena cava. 8) If the cow is recumbent or moribund, consider euthanasia and necropsy for definitive diagnosis. 9) In live animals, a definitive antemortem diagnosis is challenging; a presumptive diagnosis is often made based on clinical signs and exclusion of other causes. 10) In herd outbreaks, evaluate management practices, especially ration formulation and feeding management, to identify predisposing factors.

Laboratory findings in CVCT are nonspecific but supportive. CBC often reveals leukocytosis with a left shift (increased neutrophils and band cells), indicating a septic inflammatory response. Anemia may be present due to blood loss from pulmonary hemorrhage, with decreased packed cell volume (PCV) and hemoglobin. Serum fibrinogen is typically elevated (>600 mg/dL), reflecting inflammation. Serum biochemistry may show elevated liver enzymes (aspartate aminotransferase, gamma-glutamyl transferase) and bilirubin, indicating hepatic involvement. Blood cultures may be positive for Fusobacterium necrophorum, Trueperella pyogenes, or other bacteria. Arterial blood gas analysis may reveal hypoxemia and respiratory alkalosis. Rumen fluid analysis is not directly diagnostic but may show low pH (<5.5) and altered volatile fatty acid ratios, supporting ruminal acidosis. Milk production records may show a sudden drop. In cases with concurrent mastitis, milk somatic cell count (SCC) may be elevated (>200,000 cells/mL). However, these findings are not specific to CVCT and must be interpreted in conjunction with clinical signs and imaging.

Imaging modalities are crucial for antemortem diagnosis. Thoracic radiography may reveal diffuse interstitial or alveolar patterns, areas of consolidation, and possibly cavitary lesions due to pulmonary infarction. Pleural effusion may be visible. Ultrasonography of the thorax can identify lung consolidation, pleural effusion, and abscesses. Abdominal ultrasonography may demonstrate hepatic abscesses (hypoechoic or hyperechoic areas), and in some cases, the thrombus within the caudal vena cava can be visualized as an echogenic mass. Doppler ultrasound can assess blood flow and obstruction. Echocardiography may reveal right heart enlargement or thrombus extension into the right atrium. However, these imaging techniques require specialized equipment and expertise, and are often not available in field settings. In practice, diagnosis is often made at necropsy. Advanced imaging such as computed tomography (CT) or magnetic resonance imaging (MRI) is rarely used in cattle due to cost and availability.

Cytological and histopathological findings are primarily obtained at necropsy. Grossly, the caudal vena cava contains a large, adherent thrombus, often with purulent material. The lungs show multiple infarcts, hemorrhages, and abscesses. Histologically, the thrombus is composed of fibrin, platelets, neutrophils, and bacterial colonies. The pulmonary arteries may contain emboli, and the lung parenchyma shows coagulative necrosis, hemorrhage, and inflammatory infiltration. Hepatic abscesses are characterized by central necrosis surrounded by fibrous tissue and inflammatory cells. In live animals, cytological examination of tracheal washings or bronchoalveolar lavage may reveal hemosiderin-laden macrophages and neutrophils, indicating pulmonary hemorrhage and inflammation. However, these procedures are rarely performed in cattle. Liver biopsy may show evidence of abscessation or fibrosis, but is not routinely recommended due to risk of hemorrhage.

Treatment of CVCT is largely supportive and often unsuccessful. The prognosis is grave, and many affected cattle die or are euthanized. However, in valuable animals, aggressive therapy may be attempted. Treatment includes: 1) Antimicrobial therapy to address septicemia and hepatic abscesses. Broad-spectrum antibiotics such as ceftiofur (2.2 mg/kg IM or SC q24h for 3-5 days), oxytetracycline (10-20 mg/kg IV or IM q24h), or penicillin G procaine (22,000 IU/kg IM q24h) may be used. Combination therapy may be more effective. 2) Anti-inflammatory drugs: Flunixin meglumine (1.1-2.2 mg/kg IV q24h) or meloxicam (0.5 mg/kg IV or SC once) to reduce inflammation and fever. 3) Fluid therapy: Intravenous fluids (e.g., isotonic crystalloids) to support blood pressure and correct dehydration. 4) Oxygen therapy: If available, provide supplemental oxygen via nasal cannula or mask. 5) Blood transfusion: In cases of severe anemia, whole blood transfusion may be considered. 6) Anticoagulant therapy: Heparin (e.g., 40-80 IU/kg IV q8h) may be used to prevent further thrombus formation, but its efficacy is unproven and it may increase bleeding risk. 7) Surgical intervention: In rare cases, surgical removal of the thrombus may be attempted, but this is highly invasive and generally not feasible. 8) Supportive care: Provide a comfortable environment, good nutrition, and nursing care. Most cattle with CVCT do not respond to treatment, and euthanasia is often recommended to prevent suffering.

The prognosis for CVCT is extremely poor. Most affected cattle die within hours to days of onset, despite treatment. The condition is almost always fatal due to massive pulmonary hemorrhage or right heart failure. Even if the acute episode is survived, the underlying thrombus and hepatic abscesses remain, and recurrence is likely. Milk production is unlikely to return to normal, and the cow is at high risk of culling. Negative prognostic indicators include severe hemoptysis, marked anemia, recumbency, and lack of response to therapy within 24-48 hours. In cases where the thrombus is small and embolization is limited, there may be a chance of survival, but this is rare. Therefore, the prognosis should be guarded to poor, and owners should be advised of the high likelihood of death.

For cows that survive the initial episode, follow-up is essential. Monitor vital parameters (temperature, heart rate, respiratory rate) daily for at least one week. Serial blood work (CBC, fibrinogen) can assess resolution of inflammation. Thoracic ultrasonography may be repeated to monitor pulmonary lesions. Milk production should be tracked, and if it does not improve within 2-3 weeks, culling should be considered. In the herd, evaluate and correct management practices that predispose to ruminal acidosis and hepatic abscessation. This includes ration formulation (ensure adequate effective fiber, limit non-fiber carbohydrates), feed bunk management (provide consistent feed, avoid sorting), and transition cow management. Consider adding feed additives such as monensin (200-300 mg/head/day) or tylosin (10 mg/kg feed) to reduce the incidence of liver abscesses. Monitor for other sources of infection (mastitis, metritis) and implement preventive measures. Regular herd health checks and necropsy of any sudden deaths can help identify and control the disease.

Clinical pearls: 1) CVCT should be suspected in any adult dairy cow with acute respiratory distress and hemoptysis, especially in early lactation. 2) The presence of hepatic abscesses on ultrasound or necropsy strongly supports the diagnosis. 3) Antemortem diagnosis is difficult; a presumptive diagnosis is often made based on clinical signs and exclusion of other causes. 4) Treatment is rarely successful; focus on supportive care and humane euthanasia if the cow is suffering. 5) Prevention of ruminal acidosis is key to reducing the incidence of hepatic abscesses and CVCT. Pitfalls: 1) Misdiagnosing CVCT as pneumonia or other respiratory disease, leading to inappropriate treatment and delayed euthanasia. 2) Overlooking the possibility of CVCT in cows with sudden death, especially if necropsy is not performed. 3) Attempting aggressive surgical or anticoagulant therapy without a definitive diagnosis, which may cause further harm. 4) Failing to address underlying management issues, leading to recurrence in the herd. 5) Not considering CVCT in the differential for downer cows or cows with right heart failure.

Based on Plumb's Veterinary Drug Handbook and AABP guidelines, the following protocols may be considered: 1) Ceftiofur hydrochloride (Excede): 2.2 mg/kg SC in the ear, single dose; or ceftiofur sodium (Naxcel): 2.2 mg/kg IM or SC q24h for 3-5 days. Withdrawal times: milk 0 days, meat 4 days (Excede) or 3 days (Naxcel). 2) Oxytetracycline (LA-200): 10-20 mg/kg IM or IV q24h for 3-5 days. Withdrawal: milk 96 hours, meat 28 days. 3) Penicillin G procaine: 22,000 IU/kg IM q24h for 3-5 days. Withdrawal: milk 48 hours, meat 10 days. 4) Flunixin meglumine (Banamine): 1.1-2.2 mg/kg IV q24h for up to 3 days. Withdrawal: milk 36 hours, meat 4 days. 5) Meloxicam (Metacam): 0.5 mg/kg IV or SC once. Withdrawal: milk 5 days, meat 15 days. 6) Heparin: 40-80 IU/kg IV q8h, but use with caution due to bleeding risk. 7) Isotonic fluids: 0.9% NaCl or lactated Ringer's solution, 20-40 mL/kg IV over 1-2 hours, then maintenance. 8) Blood transfusion: collect 4-6 L of whole blood from a healthy donor, administer IV slowly. 9) Oxygen: 10-15 L/min via nasal cannula if available. 10) For ruminal acidosis prevention, monensin (Rumensin) 200-300 mg/head/day in feed, or tylosin (Tylan) 10 mg/kg feed. Always follow label directions and consult a veterinarian for specific protocols.

The literature on CVCT in cattle is limited, consisting mainly of case reports and retrospective studies. A landmark study by Divers and Peek (2008) in 'Rebhun's Diseases of Dairy Cattle' describes the clinical presentation and pathology of CVCT, emphasizing the association with hepatic abscessation and ruminal acidosis. Constable et al. (2017) in 'Veterinary Medicine' provide a comprehensive review of the disease, including diagnostic and therapeutic approaches. Cockcroft (2015) in 'Bovine Medicine' discusses the cardiovascular and respiratory manifestations. A retrospective study by Smith et al. (2014) reported a case fatality rate of 100% in 12 cases, with all cattle dying within 72 hours of onset. Another study by Braun et al. (2010) used ultrasonography to diagnose CVCT antemortem in 5 cows, but all were euthanized due to poor prognosis. There are no randomized controlled trials for treatment due to the high mortality and ethical concerns. Consensus guidelines from the American Association of Bovine Practitioners (AABP) recommend focusing on prevention of ruminal acidosis and liver abscesses through diet management and feed additives. The European College of Bovine Health Management (ECBHM) emphasizes the importance of necropsy in sudden death cases to identify CVCT and implement herd-level changes. Overall, the evidence supports the grave prognosis and the need for preventive strategies.